Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Finasteride causes lasting fertility decrease in rats.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

The gel made of minoxidil and hydroxypropyl-β-cyclodextrin improves hair growth and is good for long-term use.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

No link found between specific genes and female pattern hair loss.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride exposure harms tadpole reproduction and hormone balance.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Treat pattern hair loss with finasteride and topical minoxidil.

Minoxidil may cause heart issues in guinea pigs, suggesting potential harm for users with heart conditions.